|
| Exchange Disseminated Time | Gufic Biosciences Ltd has informed BSE that the Company is emerging as a strong player in the area of biotechnology having manufactured many biotech products in the area of infertility and bleeding disorder.
The Company is now launching streptokinase and urokinase. These two thrombolytic products have very good potential in Indian market. The Company has also tied up with some other Indian companies for marketing of these products.
Indian patients will benefit from these import substitutes as, the products are manufactured indigenously. |
|
|